13:30 – CHAIR INTRODUCTION

Chair: TBC

13:35 – FIRESIDE CHAT

Speakers:

Takis Athanasopoulos, Head of Vector Innovation & Vector Development Cell & Gene Therapy, GSK

Hemant Dhame, Head of Process Development – Gene Therapy Vector Facility, King’s College London

14:00 – CASE STUDY: SCALABLE PURIFICATION OF RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS 

Speakers: Emmanuelle Cameau, Strategic Technology Partnership Leader – Cell & Gene Therapy, Pall Corporation

14:20 – CASE STUDY:

Speaker: Hemant Dhame, Head of Process Development, King’s College London

14:40 – Q&A WITH SESSION SPEAKERS

Speakers:

Emmanuelle Cameau, Strategic Technology Partnership Leader – Cell & Gene Therapy, Pall Corporation

Hemant Dhame, Head of Process Development, King’s College London